PAUL F CHEBIB
Allopathic & Osteopathic Physicians|Internal Medicine BROWNFIELD, TX NPI 1730101965
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine TX Acerta Pharma LLC All categories
General Payments — all program years on this page
$2,406.60
- Category: General Payments
- Program years: PY2018–2024
- Record count: 140
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $173.76 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $173.76 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $48.77 | 2 |
| Teva Pharmaceuticals USA, Inc. | $31.27 | 2 |
| EISAI INC. | $31.16 | 1 |
| ITI, Inc. | $23.38 | 1 |
| Lundbeck LLC | $22.18 | 1 |
| Merck Sharp & Dohme Corporation | $17.00 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1105468737 | AstraZeneca Pharmaceuticals LP | $28.77 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105620361 | AstraZeneca Pharmaceuticals LP | $20.00 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110771899 | Eisai Inc. | $31.16 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141950537 | Merck Sharp & Dohme LLC | $17.00 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143205562 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $23.38 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1145904313 | Lundbeck LLC | $22.18 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151569625 | Teva Pharmaceuticals USA, Inc. | $13.59 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151569627 | Teva Pharmaceuticals USA, Inc. | $17.68 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.